Inhibikase Therapeutics to Present Data from Phase 1/1b stud

IkT-148009 was well-tolerated with high systemic exposure and persistent penetration into the central nervous system (CNS) in older and elderly he...

Related Keywords

Boston , Massachusetts , United States , Georgia , France , Spain , Atlanta , Madrid , Miltonh Werner , Alex Lobo , Milton Werner , Movement Disorders , Company Phase , Linkedin , Inhibikase Therapeutics Inc , Twitter , Company Contact , Nasdaq , Conference Center , Youtube , International Congress , Prnewswire Inhibikase Therapeutics Inc , Madrid Marriott Auditorium Hotel , Facebook , Sternir Inc , Abelson Tyrosine Kinases , France Gallery , Yahr About Inhibikase , Abelson Tyrosine Kinase , Ableson Tyrosine , Multiple System Atrophy , Private Securities Litigation Reform Act ,